Clinical Trials
3 trialsNCT04744116 2026-05-05
Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT06849921 2025-02-27
Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors
Ruijin Hospital
Phase NA Active not recruiting
NCT01947322 2017-08-29
NK
Assistance Publique - Hôpitaux de Paris
Phase 1/2 Completed